Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma

Information

• Research Project
• 9645871

• ApplicationId

  9645871

• Core Project Number

  R44CA206663

• Full Project Number

  4R44CA206663-02

• Serial Number

  206663

• FOA Number

  PA-15-269

• Sub Project Id

• Project Start Date

  6/3/2016 - 8 years ago

• Project End Date

  5/31/2020 - 4 years ago

• Program Officer Name

  FRANCA-KOH, JONATHAN C

• Budget Start Date

  6/1/2018 - 6 years ago

• Budget End Date

  5/31/2019 - 5 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  6/1/2018 - 6 years ago

Organizations

• KALYRA PHARMACEUTICALS, INC.

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  1139689

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:1139689\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  KALYRA PHARMACEUTICALS, INC.

• Organization Department

• Organization DUNS

  079175579

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921211123

• Organization District

  UNITED STATES